Robert Michael Poole, M.D., FACP, is a neurologist and internist with a successful career in large and small biotechnology companies developing medicines for diseases of the nervous system.
Dr. Poole served in a series of scientific and senior leadership positions at Parke Davis, Pfizer (NYSE: PFE), Wyeth, AstraZeneca (NASDAQ: AZN) where he led the Neuroscience Innovative Medicines Unit and later in the Office of the President for Global Health at The Bill and Melinda Gates Foundation where he focused on external investments and development of technology platforms. He has experience working as a venture partner at both Biomatics Capital and at Arch Ventures, where he helped source innovative investments in neuroscience and served portfolio companies in operating roles. He also serves as an advisor to the Alzheimer’s Disease Diagnostic Initiative for Gates Ventures.
He holds a medical degree from the University of California, San Diego School of Medicine and a Bachelor of Arts from the University of California, Berkeley. He trained in internal medicine at Strong Memorial Hospital, University of Rochester and in neurology at the University of Michigan Medical Center.